23 May 2013
Keywords: generex, enters, 25m, oralin, deal, canadas, biotechnology
Article | 05 July 2004
Canadas Generex Biotechnology, a leader in the area of buccal drugdelivery, announced today that it has signed a letter of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2004
22 May 2013
© 2013 thepharmaletter.com